JP2025072575A5 - - Google Patents

Info

Publication number
JP2025072575A5
JP2025072575A5 JP2025019638A JP2025019638A JP2025072575A5 JP 2025072575 A5 JP2025072575 A5 JP 2025072575A5 JP 2025019638 A JP2025019638 A JP 2025019638A JP 2025019638 A JP2025019638 A JP 2025019638A JP 2025072575 A5 JP2025072575 A5 JP 2025072575A5
Authority
JP
Japan
Prior art keywords
gene segment
influenza virus
pharmaceutical formulation
influenza
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025019638A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025072575A (ja
Filing date
Publication date
Priority claimed from JP2021572529A external-priority patent/JP7756911B2/ja
Application filed filed Critical
Publication of JP2025072575A publication Critical patent/JP2025072575A/ja
Publication of JP2025072575A5 publication Critical patent/JP2025072575A5/ja
Pending legal-status Critical Current

Links

JP2025019638A 2019-06-07 2025-02-07 インフルエンザウイルスバックボーン Pending JP2025072575A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201962858737P 2019-06-07 2019-06-07
US62/858,737 2019-06-07
JP2021572529A JP7756911B2 (ja) 2019-06-07 2020-06-05 インフルエンザウイルスバックボーン
PCT/US2020/036455 WO2020247844A1 (en) 2019-06-07 2020-06-05 Influenza virus backbone

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2021572529A Division JP7756911B2 (ja) 2019-06-07 2020-06-05 インフルエンザウイルスバックボーン

Publications (2)

Publication Number Publication Date
JP2025072575A JP2025072575A (ja) 2025-05-09
JP2025072575A5 true JP2025072575A5 (enExample) 2026-01-09

Family

ID=73652317

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021572529A Active JP7756911B2 (ja) 2019-06-07 2020-06-05 インフルエンザウイルスバックボーン
JP2025019638A Pending JP2025072575A (ja) 2019-06-07 2025-02-07 インフルエンザウイルスバックボーン

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2021572529A Active JP7756911B2 (ja) 2019-06-07 2020-06-05 インフルエンザウイルスバックボーン

Country Status (9)

Country Link
US (1) US20220241397A1 (enExample)
EP (1) EP3980060A4 (enExample)
JP (2) JP7756911B2 (enExample)
KR (1) KR20220088530A (enExample)
CN (1) CN114072169A (enExample)
AU (1) AU2020286472A1 (enExample)
CA (2) CA3142740A1 (enExample)
MX (1) MX2021014848A (enExample)
WO (1) WO2020247844A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023534840A (ja) * 2020-07-21 2023-08-14 フルゲン， インコーポレイテッド Ｍ２／ｂｍ２欠失インフルエンザベクターを使用したワクチン
KR20230041775A (ko) * 2020-07-21 2023-03-24 플루젠, 인코퍼레이티드 인플루엔자 바이러스 백본
WO2025081053A1 (en) * 2023-10-11 2025-04-17 Flugen, Inc. Formulations for thermostable vaccines

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040180058A1 (en) * 2002-12-20 2004-09-16 Shneider Alexander M. Vaccine compositions and methods
EP1477802A1 (en) * 2003-05-16 2004-11-17 Erasmus Universiteit Rotterdam Method for selecting and producing vaccine components and vaccines based thereon
ES2813347T3 (es) 2009-10-26 2021-03-23 Wisconsin Alumni Res Found Virus recombinantes de la influenza de alto título con replicación mejorada en células Vero
FR2962739B1 (fr) * 2010-07-13 2014-01-31 Univ Claude Bernard Lyon Souches virales modifiees et procede pour ameliorer la production de semences vaccinales de virus influenza
MX346625B (es) 2011-06-24 2017-03-27 Flugen Inc Mutantes de virus de influenza y usos para los mismos.
AU2014290203B2 (en) * 2013-07-15 2020-12-24 Wisconsin Alumni Research Foundation High titer recombinant influenza viruses with enhanced replication in MDCK or vero cells or eggs

Similar Documents

Publication Publication Date Title
JP2025072575A5 (enExample)
JP2022160401A5 (enExample)
US6468544B1 (en) Interferon inducing genetically engineered attenuated viruses
CN102257135B (zh) 流感疫苗的生产
JP2024177515A5 (enExample)
JP2018504412A5 (enExample)
JP6692835B2 (ja) 感染性疾患の予防及び／又は処置並びに腫瘍性疾患の処置のための弱毒化インフルエンザベクター
JP2016506416A5 (enExample)
JP2009511084A5 (enExample)
JP2010508030A5 (enExample)
Martín-Benito et al. Influenza virus transcription and replication
MX2022013462A (es) Variantes, formulaciones y metodos adeno-asociados para suministro pulmonar.
JP2019214579A5 (enExample)
WO2024239980A1 (zh) 重组表达蛋白在预防/或治疗呼吸道疾病中的应用
James et al. Differential activities of alpha/beta IFN subtypes against influenza virus in vivo and enhancement of specific immune responses in DNA vaccinated mice expressing haemagglutinin and nucleoprotein
JP2018501258A5 (enExample)
WO2020152318A3 (en) High growth influenza virus
JP2020515283A5 (enExample)
JP2019534242A5 (enExample)
CN108025055A (zh) 多价肠道病毒疫苗组合物及其相关用途
Fonseca et al. A recombinant influenza virus vaccine expressing the F protein of respiratory syncytial virus
BR112023004433A2 (pt) Ácido nucleico, vetor, segmento genômico viral, vírus, composição farmacêutica, método para induzir ou aumentar uma resposta imune contra o vírus influenza, vírus recombinante, método para induzir uma resposta imune em um sujeito em necessidade e polipeptídeo
Su et al. Emergence and pandemic potential of avian influenza a (H7N9) virus
KR102182987B1 (ko) 재조합 인플루엔자 a 바이러스 h5n1주 및 이를 포함하는 고병원성 인플루엔자 a 바이러스 백신 조성물
US20220226463A1 (en) Recombinant non-structural protein 1, recombinant influenza virus and immunological composition including the same, and method of treating or preventing disease or condition caused by or associated with influenza virus